Skip to main navigation Skip to search Skip to main content

Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children

  • A. Drilon
  • , T. W. Laetsch
  • , S. Kummar
  • , S. G. Dubois
  • , U. N. Lassen
  • , G. D. Demetri
  • , M. Nathenson
  • , R. C. Doebele
  • , A. F. Farago
  • , A. S. Pappo
  • , B. Turpin
  • , A. Dowlati
  • , M. S. Brose
  • , L. Mascarenhas
  • , N. Federman
  • , J. Berlin
  • , W. S. El-Deiry
  • , C. Baik
  • , J. Deeken
  • , V. Boni
    • R. Nagasubramanian, M. Taylor, E. R. Rudzinski, F. Meric-Bernstam, D. P.S. Sohal, P. C. Ma, L. E. Raez, J. F. Hechtman, R. Benayed, M. Ladanyi, B. B. Tuch, K. Ebata, S. Cruickshank, N. C. Ku, M. C. Cox, D. S. Hawkins, D. S. Hong, D. M. Hyman

Research output: Contribution to journal › Article › peer-review

2584   Link opens in a new tab Citations (SciVal)

Fingerprint

Dive into the research topics of 'Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science